Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com
Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.
Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Oct 22 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that President and CEO John Baust, Ph.D., is scheduled to make an investor presentation at TechVest's 4th Annual Healthcare...
- Oct 21 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced today that it has selected Irvine, CA-based Allen & Caron Inc, a full-service investor and media relations firm, to support its investor,...
- Oct 16 2002
BioLife Solutions, Inc. (BULLETIN BOARD: BLFS) announced that the National Institutes of Health (NIH) has awarded the Company a grant of $158,000 under the NIH's Small Business Innovation Research...
- Sep 30 2002Reflects Company's Focus as Developer and Marketer of Cell Preservation Technology to Biotechnology Industry
Cryomedical Sciences, Inc. (BULLETIN BOARD: BLFS) announced that effective September 30, 2002, the Company has changed its name to BioLife Solutions, Inc. and will begin to trade under the new...
- Jun 27 2002Board Approves Name Change to BioLife Solutions, Inc., New CEO And New Strategic Focus
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced today that it has completed the sale of its cryosurgery product line and related intellectual property assets to Irvine, CA-based...
- May 29 2002Announces New CEO, Proposed Name Change and New Strategic Focus on Proprietary Cell and Tissue Preservation Products
Cryomedical Sciences, Inc. (BULLETIN BOARD: CRYM) (CMS) announced that it has executed a definitive agreement to sell its cryosurgical product line and related intellectual property assets to...